Press releases


Long COVID ‘indistinguishable’ from other post-viral syndromes a year after infection

Long COVID appears to manifest as a post-viral syndrome indistinguishable from seasonal influenza and other respiratory illnesses, with no evidence of increased moderate-to-severe functional limitations a year after infection, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).

 

You can read the full press release here.

 

Optimising preventive measures to stop surgical infections – why are we doing what we are doing?

A talk to be given at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) will look at improving preventive measures to stop surgical infections. It will also ask why we are doing what we are doing, especially when some interventions lack quality evidence or in fact in some cases any evidence to back them. The presentation will be given by Professor Hilary Humphreys, RCSI University of Medicine and Health Sciences, Dublin, Ireland – who will spell out the need for evidence from which to make recommendations. 

 

Read the full press release here.

 

Knowing when you can return to work or send your child back to school/nursery – personalised care for influenza and flu-like illness

A talk to be given at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors can work more closely together and be able to more accurately determine when the infectious part of the illness has passed and it is safe for someone to return to work or send their child back to school or nursery. The talk will be given by Professor Barbara Rath, Co-founder & Chair of Vaccine Safety Initiative (VIVI) and Research Director, Université de Bourgogne Franche Comté, France. 

 

The full press release is available here.

 

Artificial intelligence has huge potential in infection control, as long as the right questions are asked and safeguards are in place

A talk to be given at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will look at the many ways artificial intelligence can help prevent infectious disease outbreaks including ensuring staff wear personal protective equipment correctly and managing day-to-day hospital activities such as medication prescription and cleaning. The presentation will be given by Prof Richard Drew, Rotunda Hospital and CHI at Temple St, Irish Meningitis and Sepsis Reference Laboratory and the Royal College of Surgeons in Ireland, Dublin, Ireland. 

 

Read the full press release here.

 

How artificial intelligence could improve speed and accuracy of response to infectious disease outbreaks in hospitals, and even prevent them

A talk to be given at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will highlight the potential artificial intelligence (AI) has to improve the speed and accuracy of investigations into infectious disease outbreaks in hospitals, and potentially provide real time information to stop or prevent them. The talk will be given by Dr Jonas Marschall, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA. 

 

The full press release is available here.